logo
episode-header-image
Dec 2020
22m 18s

The Beginning of the End of the Pandemic

The New York Times
About this episode
In Britain, news that the country had become the first to start administering a fully tested coronavirus vaccine was met with hope, excitement — and some trepidation. Amid the optimism that normal life might soon resume, there is also concern. Has the vaccine been developed too fast? Is it safe? On today’s episode, we examine how Britons feel about the pros ... Show More
Up next
Today
Trump’s D.O.J. Went After the Fed. It Backfired.
The Trump administration’s decision to open a criminal investigation into the Federal Reserve chairman, Jerome H. Powell, has stunned the worlds of business and politics.Colby Smith and Glenn Thrush, who have been covering the news, discuss how the investigation came about, the p ... Show More
28m 15s
Yesterday
Iran on the Brink
Iran is experiencing expansive protests after economic grievances snowballed over the past two weeks into a broader challenge to the country’s authoritarian clerical rulers.In recent days, a full picture of the government’s crackdown on demonstrators has emerged, garnering global ... Show More
28m 46s
Jan 13
The United States' Aspirations for Venezuela's Oil
In the days since deposing Nicolás Maduro, President Trump has given several justifications for his dramatic actions in Venezuela. But perhaps most central to his ambitions is opening Venezuela’s oil fields to American companies.Anatoly Kurmanaev, who covers Venezuela, explains t ... Show More
40m 44s
Recommended Episodes
Dec 2020
Race for the Vaccine
On the same day the COVID-19 death toll surpassed 300,000 in the United States, the first vaccines are being administered, finally giving millions of Americans hope for a better future and a return to normalcy. We explore how officials expect to deliver a safe and effective vacci ... Show More
37m 42s
Nov 2020
The Vaccine: The first glimmer of hope
<p>The first in an unfolding miniseries -&nbsp;<em>The Vaccine</em>&nbsp;- tracking the progress of those tackling this historic challenge. We'll be making sense of the latest developments as they happen,&nbsp;taking an inside look at the vaccine industry,&nbsp;and learning from ... Show More
32m 37s
Dec 2020
Vaccine hesitancy, the next pandemic hurdle
As the Pfizer-BioNTech vaccine rolls out across the country, and other vaccines await imminent regulatory approval, many public health experts are focusing on the issue of vaccine hesitancy. Canada's Chief Public Health Officer Dr. Theresa Tam has spoken out about the "moveable m ... Show More
31m 47s
Dec 2020
Vaccino (with an extra shot)
A great day for science, a bad day for Covid-19. As the first Pfizer vaccines are given to patients in the UK, the Oxford-AstraZeneca vaccine publishes its data. Adam and Fergus chat to virologist Dr Elisabetta Groppelli about how the rollout might go - and learn some Italian whi ... Show More
31m 9s
Jan 2021
Why U.S. Vaccinations Started Slow And What We Know About The New Coronavirus Variant
Initially, U.S. officials predicted that as many as 20 million Americans would be fully vaccinated before the end of 2020. And while that many vaccine doses were distributed, only a fraction of them have been administered. The federal government has given states control over dist ... Show More
12m 21s
Oct 2021
Sick Money (Pt 2): How Big Pharma made a killing from the pandemic
<p>The second of two episodes this week, taking a deep dive into the pharmaceutical industry.</p><p>Big drug companies have won plaudits for their work producing Covid vaccines within a year of the start of the pandemic. How much money are they making from them? And why are vacci ... Show More
24m 39s